Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors. 2017

Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China.

This study mainly focused on the modification of the X2 position in febuxostat analogs. A series of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives (1a-s) with an N atom occupying the X2 position was designed and synthesized. Evaluation of their inhibitory potency in vitro on xanthine oxidase indicated that these compounds exhibited micromolar level potencies, with IC50 values ranging from 0.21µM to 26.13μM. Among them, compound 1s (IC50=0.21μM) showed the most promising inhibitory effects and was 36-fold more potent than allopurinol, but was still 13-fold less potent than the lead compound Y-700, which meant that a polar atom fused at the X2 position could be unfavorable for potency. The Lineweaver-Burk plot revealed that compound 1s acted as a mixed-type xanthine oxidase inhibitor. Analysis of the structure-activity relationships demonstrated that a more lipophilic ether tail (e.g., meta-methoxybenzoxy) at the 4'-position could benefit the inhibitory potency. Molecular modeling provided a reasonable explanation for the structure-activity relationships observed in this study.

UI MeSH Term Description Entries
D002264 Carboxylic Acids Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. Carboxylic Acid,Acid, Carboxylic,Acids, Carboxylic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D014969 Xanthine Oxidase An iron-molybdenum flavoprotein containing FLAVIN-ADENINE DINUCLEOTIDE that oxidizes hypoxanthine, some other purines and pterins, and aldehydes. Deficiency of the enzyme, an autosomal recessive trait, causes xanthinuria. Hypoxanthine Oxidase,Hypoxanthine Dehydrogenase,Hypoxanthine-Xanthine Oxidase,Purine-Xanthine Oxidase,Dehydrogenase, Hypoxanthine,Hypoxanthine Xanthine Oxidase,Oxidase, Hypoxanthine,Oxidase, Hypoxanthine-Xanthine,Oxidase, Purine-Xanthine,Oxidase, Xanthine,Purine Xanthine Oxidase
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
March 2022, Bioorganic & medicinal chemistry letters,
Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
August 2008, Acta crystallographica. Section E, Structure reports online,
Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
February 2018, European journal of medicinal chemistry,
Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
April 2015, Bioorganic chemistry,
Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
May 2009, Acta crystallographica. Section E, Structure reports online,
Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
October 2022, Bioorganic chemistry,
Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
January 2020, Bioorganic chemistry,
Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
January 2020, European journal of medicinal chemistry,
Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
November 2019, European journal of medicinal chemistry,
Ting-Jian Zhang, and Qing-Xia Wu, and Song-Ye Li, and Lin Wang, and Qi Sun, and Yi Zhang, and Fan-Hao Meng, and Hua Gao
August 1986, Il Farmaco; edizione scientifica,
Copied contents to your clipboard!